Outlook Therapeutics stock slides after pricing $5M offering
Source: SeekingAlpha
2026-03-24 07:11:45 ET
More on Outlook Therapeutics
- Third Time's The Charm: Outlook Therapeutics' Lytenava Heads To FDA, Again
- Biggest stock movers Tuesday: CLB, OTLK, and more
- Outlook Therapeutics drops 80% on CRL for BLA for wet AMD asset
- Seeking Alpha’s Quant Rating on Outlook Therapeutics
- Historical earnings data for Outlook Therapeutics
Read the full article on Seeking Alpha
For further details see:
Outlook Therapeutics stock slides after pricing $5M offering
Outlook Therapeutics Inc.
NASDAQ: OTLK
OTLK Trading
-4.08% G/L:
$0.20 Last:
3,788,477 Volume:
$0.2116 Open:
OTLK Latest News
OTLK Stock Data
$32,307,405
71,451,190
1.63%
24
N/A
Biotechnology & Life Sciences
Healthcare
US
Iselin
